孟丽萍

[摘要] 目的 探讨个体化营养治疗对交界性糖耐量异常孕妇糖脂代谢及妊娠结局的影响。方法 选取2018年1—12月医院收治的80例交界性糖耐量异常孕妇作为研究对象，随机分为观察组和对照组各40例。比较两组孕妇的糖脂代谢情况、妊娠结局。 结果 观察组治疗后的糖脂代谢指标、妊娠结局均明显优于对照组（P<0.05）。 结论 个体化营养治疗能明显改善交界性糖耐量异常孕妇的妊娠结局及糖脂代谢水平。

[关键词] 交界性糖耐量异常;孕妇;糖脂代谢;妊娠结局

[中图分类号] R714.256          [文献标识码] A          [文章编号] 1672-4062（2020）01（b）-0005-03

[Abstract] Objective To investigate the effects of individualized nutrition therapy on glucose and lipid metabolism and pregnancy outcome in pregnant women with borderline impaired glucose tolerance. Methods Eighty women with borderline impaired glucose tolerance who were admitted to hospital from January to December 2018 were enrolled in the study. They were randomly divided into observation group and control group. The glucose and lipid metabolism and pregnancy outcomes of the two groups of pregnant women were compared. Results The glucose and lipid metabolism indexes and pregnancy outcomes of the observation group were significantly better than those of the control group（P<0.05）. Conclusion Individualized nutritional therapy can significantly improve the pregnancy outcome and glucose and lipid metabolism levels in pregnant women with borderline impaired glucose tolerance.

[Key words] Borderline impaired glucose tolerance; Pregnant women; Glycolipid metabolism; Pregnancy outcome

交界性糖耐量異常是孕妇妊娠期的一种常见并发症，易增加其分娩时的剖宫产率及母婴并发症发生率，若未给予有效干预易导致孕妇进展为妊娠期糖尿病，而妊娠期糖尿病会增加妊娠期并发症率及不良母婴妊娠结局风险[1]。临床研究表明，孕期实施饮食干预有助于改善交界性糖耐量异常孕妇的妊娠结局[2]。个体化医学营养治疗能够针对不同孕妇的病情采取针对性的营养治疗，有助于改善孕妇妊娠期的营养状态。因此，该文选取2018年1—12月收治的80例交界性糖耐量异常孕妇作为研究对象，旨在探讨个体化营养治疗对交界性糖耐量异常孕妇糖脂代谢及妊娠结局的影响。报道如下。

1  资料与方法

1.1  一般资料

该研究选取院收治的80例交界性糖耐量异常孕妇作为研究对象，随机分为观察组和对照组各40例。观察组：年龄23～37岁，平均（30.24±5.42）岁;孕周22～30周，平均（26.13±1.50）周;初产妇24例，经产妇16例。对照组：年龄22～37岁，平均（30.23±5.41）岁;孕周22～32周，平均（26.25±1.54）周;初产妇25例，经产妇15例。患者均对该研究知情，并签署知情同意书。……